Mitochondrial dysfunction and rod-like lesions associated with administration of β2 adrenoceptor agonist formoterol

Neuromuscular Disorders

Volumn 14, Issue 6, 2004, Pages 375-377

  Kiernan, Matthew C ^a,b   Bullpitt, Peter ^b   Chan, Jane H L ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Formoterol; Mitochondria; Myotoxicity; Nemaline myopathy

Indexed keywords

ALLOPURINOL; ALPHA ACTININ; ANTIBODY; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CARBONATE; CREATINE KINASE; CYTOCHROME C OXIDASE; FLUTICASONE; FORMOTEROL; FUROSEMIDE; PANTOPRAZOLE; POTASSIUM; PREDNISONE; SUCCINATE DEHYDROGENASE; TERBUTALINE;

ADULT; ANAMNESIS; ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; GENERAL CONDITION IMPROVEMENT; HISTOCHEMISTRY; HUMAN; IMMUNOCYTOCHEMISTRY; LABORATORY TEST; MITOCHONDRIAL ROD LIKE LESION; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ACTININ; ADENOSINE TRIPHOSPHATASES; ADRENERGIC BETA-AGONISTS; CREATINE KINASE; ETHANOLAMINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCULAR ATROPHY; RECEPTORS, ADRENERGIC, BETA-2; SUCCINATE DEHYDROGENASE; TIME FACTORS;

EID: 2442499689     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2004.02.014     Document Type: Article

References (8)

1. Argov Z., Mastaglia F.L. Drug-induced neuromuscular disorders. Walton J., Karpati G., Hilton Jones D. Walton's Disorders of Voluntary Muscle. 1994;989-1009 Churchill-Livingstone, New York
2. Argov Z., Squier W. Toxic and iatrogenic disorders. Karpati G. Structure and Molecular Basis of Skeletal Muscle Diseases. 2002;246-249 ISN Ncuropath Press, Basel
3. Dalakas M.C., Illa I., Pezeshkpour G.H., Laukaitis J.P., Cohen B., Griffin J.L. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 322:1990;1098-1105
4. Ginanneschi F., Mondelli M., Malandrini A., Gambelli S., Dotti M.T., Federico A. Nemaline myopathy: description of an adult onset case. J Submicrosc Cytol Pathol. 34:2002;105-108
5. Bartow R.A., Brogden R.N. Formoterol: An update of its pharmacological properties and therapeutic efficacy in the management of asthma. Drugs. 55:1998;303-322
6. Craig T.J., Smits W., Soontornniyomkiu V. Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol. Annals of Allergy, Asthma and Immunology. 77:1996;488-490
7. Reed C.E. Beta agonists: adrenergic bronchodilators: pharmacology and toxicity. J Allergy Clin Immunol. 76:1985;335-341
8. Bardsley R.G., Allcock S.M.J., Dawson J.M., Dumelow N.W., Higgins J.A., Lasslett Y.V., et al. Effect of β-agonists on expression of calpain and calpastatin activity in skeletal muscle. Biochimie. 74:1992;267-273